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Background: Indian data on CLABSI in PICU is scarce. Most of
the reported studies are on CRBSI or they have shown combined
adult, pediatric and neonatal data.
Methods & Materials: We conducted a retrospective study of
PICU records of the 5-year study period (January 2010 –December
2014). Patients with Central Venous Catheters (CVCs) were identi-
ﬁed. Patients with incomplete medical records or CVCs in situ for
duration less than 48 hours were excluded. CLABSI was identiﬁed
by the CDC deﬁnition. Demographic, disease related and catheter
related factorswere comparedbetween theCLABSI andnon-CLABSI
groups. Outcomes studied were length of hospital, PICU stay and
mortality. The proﬁle of organisms causing CLABSI was studied.
Results: A total of 248 patients satisﬁed the inclusion criteria
. 55 patients were excluded (Incomplete records =14, Duration of
CVC<48 hours =41). 21 CLABSIs occurred during the study period.
Multiple CVCs, neurological diagnoses and longer duration of CVCs
were associated with increased risk of CLABSI. The mean time to
CLABSI was calculated as 8±3 days (5-11 days). Duration of PICU
stay (p=0.0001) and duration of hospital stay (p =0.002) were sig-
niﬁcantly higher for the CLABSI group, though organ dysfunction
or mortality was not higher.
Gram negative organisms (n=17) caused 81% of the CLABSIs,
followed by Candida species (n =3, 14.3%) and grampositive organ-
isms (n=1, 4.7%). Pseudomonas specieswere the top isolates (n =6,
28.5%) followed by Enterobacteriaceae - E.coli (n =3 ; 17.6%) and
Klebsiella (n =3; 17.6%). 3 (17.6%) isolates of Acinetobacter species
were isolated. Only 11.7% (n=2) of the gram negative organisms
were sensitive to cephalosporins. Carbapenem resistance was seen
in 17.6% (n=3). All Candida species were azole sensitive and the
lone gram positive isolate was MRSA.
Conclusion: CLABSIs were associated with prolonged PICU and
hospital stay. Limiting the number of CVCs per patient and duration
of catheterization to less than 8 days along with intense infection
controlmeasures areneeded to reduceCLABSI rates inourPICU. The
proﬁle anddrug resistancepatterns reportedhere are verydifferent
from that quoted in the Western literature.
http://dx.doi.org/10.1016/j.ijid.2016.02.702
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Prevalence of meticillin resistant
Staphylococcus aureus and coagulase negative
staphylococci bacteremia and nasal carriage in
a tertiary care hospital, South India
V.H.B. Kumari
NIMHANS, Bengaluru, Karnataka, India
Background: Nosocomial infection is a major problem glob-
ally. Prevalence and antibiotic resistance of methicillin-resistant
Staphylococcus aureus (MRSA) strains are reported to be increas-
ing worldwide. MRSA and methicillin resistant coagulase negative
staphylococci (MRCoNS) are the important agents causing nosoco-
mial infections.
Methods & Materials: A retrospective study conducted for a
period of three years. The study was conducted to ﬁnd out the
prevalence rate of MRSA and MRCoNS in nasal swabs and also from
patients with bacteremia from hospital inpatients who were also
subjected to nasal sampling.
All isolates were identiﬁed by Clinical and Laboratory Standards
Institute (CLSI) guidelines and antibiotic susceptibility pattern
determined by modiﬁed Kirby Bauer disc diffusion method.
Results: A total of 7212 (inpatient and outpatient) nasal screen-
ing samples were included in the study in which 1871/7212
(25.95%) were Gram positive cocci.
Of them, 467/7212 (6.48%) S.aureus, 1404/7212(19.45%) CoNS
were isolated.140/467(29.98%) S.aureus were MRSA and 473/1404
(33.69%) CoNS were MRCoNS.
Out of total 2172 tested, 371(17.08%) cases had bacteremia of
which 213/371 (57.41%) hadGrampositive bacteremia-49 S.aureus
(23.0%) and 164(76.99%) CoNS. Of the 49 S.aureus, 26 were MRSA
(53.06%), and of the 164 CoNS, 90 (54.87%) were MRCoNS.
Out of total 2172 tested, 26 (12.21%)wereMRSAbacteremia and
90 (42.25%) were MRCoNS bacteremia.
Of the 371 with all bacteremia(gram positive(213) + gram neg-
ative(158)) and 213 Gram positive bacteremia, the percentage of
MRSA bacteremia was 7% and 12.23% respectively.
Corresponding nasal sampling could be done in only 72 bac-
teremic patients, of whom 6/72(8.3%) had MRSA bacteremia and
24/72 (33.33%) had MRCoNS bacteremia.
Among the corresponding tested group, 5/72(6.95%) had nasal
MRSA and 21/72(29.16%) had nasal MRCoNS
4/6(66.66%) {4/72(5.5%)} had MRSA and 8/24(33.33%)
{8/72(11.1%)}had MRCoNS in both blood and nose and rest
of the 60(dual tested) patients had differential isolation of gram
positive/gram negative/both organisms.
Conclusion: There is need for continuous monitoring of the
antimicrobial susceptibility pattern ofmethicillin resistant staphy-
lococcus aureus and methicillin resistant coagulase negative
staphylococci in bacteremic patients and also for nasal screening
and selection of evidence driven appropriate therapy, developing
theantibioticpolicyand for limiting theuseof restrictedantibiotics.
http://dx.doi.org/10.1016/j.ijid.2016.02.703
